Tinostamustine and Nivolumab in Advanced Melanoma
NCT03903458
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma
Interventions
DRUG:
Tinostamustine
Sponsor
Markus Joerger